illinois science + technology park

05/01/2026

The Illinois EDC Economic Research Center’s 2026 State of Business Report reviews the state’s economy and places Illinois’ performance in national and regional context over the past year.
https://www.illinoisedc.org/resource/the-state-of-business-2026/?

Illinois EDC’s Economic Research Center’s 2026 State of Business Report reviews the state’s economy and places Illinois’ performance in national and regional context over the past year.

05/01/2026

SCORE Chicago - 2026 Pitch Competition

Showcase your business and win your share of $15,000 in cash prizes! $5,000 for 1 winner $3,000 each for 2 winners $2,000 each for 2 winners Application Deadline: May 7, 2026 Finalists Announced: mid-June Live Pitch Presentations: July 16, 2026 @ Polsky Center for Entrepreneurship & Innovation, Chic...

04/30/2026

Biohub, the nonprofit spearheaded by Mark Zuckerberg and Priscilla Chan, is committing $500 million to help create better AI simulations of the human body

The duo will pivot their philanthropy work to AI-powered biology.

04/30/2026

U.S. life sciences deal activity

04/30/2026

Discover How the Innovation Voucher Program Can Support Your R&D
https://luma.com/mu0j6zp3?

Discover How the Innovation Voucher Program Can Support Your R&D Join this info session to learn how the Illinois Innovation Voucher Program supports research…

04/30/2026

CELEBRATING SKOKIE'S CULTURAL DIVERSITY

04/30/2026

For Emalex, the acquisition represents the culmination of years of focused development and positions its lead program for the next phase of advancement with the resources and scale of a major pharmaceutical company.
https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2026/Teva-to-AcquireEmalexBiosciences-Adding-NDA-Ready-First-in-Class-Therapy-to-Neuroscience-Pipeline-and-Accelerating-Tevas-Pivot-to-Growth-Strategy/default.aspx?

Ecopipam, Emalex’s investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with FDA Orphan Drug and Fast Track designations. The late-stage program in a high-need, specialized area of neuroscience expands Teva’s innovative medicin...

04/29/2026

The biologics segment led all segments in deal value at $3.1 billion, driven by multispecific antibody platforms expanding from oncology into immunology, while small molecules led in deal count as AI-assisted drug design and protein degrader technologies gained traction.
https://pitchbook.com/news/reports/q1-2026-biopharma-vc-trends?

Biopharma VC deal value fell to $7.2 billion in Q1 2026 as capital shifted toward exits. We examine modality trends, oncology, and obesity deal flow, and what a strengthening exit environment means for 2026.

04/28/2026

Developer of robotic medical equipment designed to transform non-invasive healthcare.

SquareMind redefines skin exams with Swan, the world's first full-body dermoscopy robot. Automated, seamless, and powered by AI technology.

04/28/2026

OpenAI is gradually shedding one of its key early partners as it looks to its next big thing: going public.
https://pitchbook.com/news/articles/openai-loosens-microsofts-grip-ahead-of-ipo-push?

OpenAI is gradually shedding one of its key early partners as it looks to its next big thing: going public.

04/27/2026

VentureCat is Northwestern's annual student startup competition.
The program culminates in a pitch competition in which a prize pool of $175K+ in non-dilutive prize money is distributed to student ventures.

VentureCat is Northwestern's annual student startup competition.

04/24/2026

The way consumers experience TV has fundamentally changed

Explore how modern consumers engage with TV across platforms, highlighting its role as a trusted, influential channel driving brand discovery and purchase decisions.